newsfilter
← Latest News
Business Wire·

Epizyme Announces Pricing of Public Offering of Common Stock

Epizyme, Inc. (NASDAQ:EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today announced the pricing of an underwritten public offering of 56,666,667 shares of its common stock at